在高级形脂肉瘤中进行全身疗法:综合性审查
Tarek Assi1, Carine Ngo2, Matthieu Faron2,3
1Sarcoma Unit, Department of Cancer Medicine, Gustave Roussy Cancer Campus, 114, Rue Edouard Vaillant, Villejuif, France. Tarek.assi@gustaveroussy.fr.
Current treatment options in oncology
|October 16, 2023
概括
形脂肪瘤 (PLPS) 治疗基于其他脂肪瘤亚型,因为数据有限. 像埃里布林这样的新疗法在晚期阶段比传统化疗更有前途.
科学领域:
- 在瘤学瘤学.
- 肉瘤研究研究 肉瘤研究
- 医学治疗学 医学治疗学
背景情况:
- 形脂肪肉瘤 (PLPS) 是一种罕见的,高等级的软组织肉瘤.
- 目前的治疗策略是从其他脂质瘤亚型中推断出来的.
- 有限的回顾性数据存在,缺乏PLPS管理的具体指南.
研究的目的:
- 审查目前用于形脂肪肉瘤的治疗方法.
- 突出在先进的PLPS中特定的全身疗法的疗效.
- 讨论软组织肉瘤治疗的不断变化的景观.
主要方法:
- 对PLPS治疗发表的回顾性数据的审查.
- 传统化疗 (多克索鲁比,吉姆西塔) 与较新的药物 (埃里布林,特拉贝克丁) 的比较.
- 对晚期疾病治疗结果的分析.
主要成果:
- 常规疗法 (多克索鲁比,凝胺) 是用于PLPS初始阶段的标准疗法.
- 埃里布林和特拉贝克丁在晚期PLPS中表现出有前途的活性.
- 追溯数据指导目前的瘤实践在没有具体指南的情况下.
结论:
- 新的全身疗法为高级PLPS提供了潜在的好处.
- 对于罕见的软组织肉瘤基因型,需要进一步的研究和适应的临床试验.
- 了解STS病理生理学可以为量身定制的治疗策略提供信息.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


